-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Roche Holding AG (OTCMKTS:RHHBY) Short Interest Update
Roche Holding AG (OTCMKTS:RHHBY) Short Interest Update
Roche Holding AG (OTCMKTS:RHHBY – Get Rating) saw a large growth in short interest in September. As of September 15th, there was short interest totalling 2,820,200 shares, a growth of 34.4% from the August 31st total of 2,097,800 shares. Based on an average daily trading volume, of 2,367,600 shares, the short-interest ratio is currently 1.2 days.
Roche Stock Down 1.2 %
Shares of RHHBY stock traded down $0.49 on Friday, reaching $40.62. The company's stock had a trading volume of 1,986,635 shares, compared to its average volume of 1,930,656. The company has a current ratio of 0.93, a quick ratio of 0.73 and a debt-to-equity ratio of 0.57. Roche has a 12-month low of $37.88 and a 12-month high of $53.86. The stock's 50 day simple moving average is $41.30 and its 200-day simple moving average is $43.42.
Get Roche alerts:Institutional Investors Weigh In On Roche
A number of large investors have recently added to or reduced their stakes in the company. Captrust Financial Advisors increased its holdings in shares of Roche by 15.0% in the second quarter. Captrust Financial Advisors now owns 46,398 shares of the company's stock worth $1,934,000 after buying an additional 6,041 shares during the period. Madison Asset Management LLC bought a new stake in shares of Roche in the second quarter worth about $2,097,000. Boston Common Asset Management LLC grew its stake in shares of Roche by 8.6% in the second quarter. Boston Common Asset Management LLC now owns 651,564 shares of the company's stock worth $27,100,000 after purchasing an additional 51,537 shares during the last quarter. Altrius Capital Management Inc bought a new stake in shares of Roche in the second quarter worth about $4,037,000. Finally, Tevis Investment Management grew its stake in shares of Roche by 46.8% in the second quarter. Tevis Investment Management now owns 17,626 shares of the company's stock worth $731,000 after purchasing an additional 5,621 shares during the last quarter. Hedge funds and other institutional investors own 0.23% of the company's stock.
Wall Street Analysts Forecast Growth
RHHBY has been the topic of a number of research reports. Cowen reduced their price objective on Roche from $58.00 to $48.00 and set an "outperform" rating on the stock in a research report on Monday, June 27th. Deutsche Bank Aktiengesellschaft reduced their price objective on Roche from CHF 350 to CHF 325 and set a "hold" rating on the stock in a research report on Friday, July 22nd. Berenberg Bank upgraded Roche from a "hold" rating to a "buy" rating in a research report on Wednesday, September 14th. Barclays reduced their price target on Roche from CHF 450 to CHF 400 and set an "overweight" rating on the stock in a research report on Tuesday, July 19th. Finally, Credit Suisse Group upgraded Roche from a "neutral" rating to an "outperform" rating in a research report on Thursday, September 15th. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $260.14.Roche Company Profile
(Get Rating)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation.
See Also
- Get a free copy of the StockNews.com research report on Roche (RHHBY)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Let Paychex Stock Work Hard For You
- Declining Profits Challenge the CarMax Value Proposition
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
Roche Holding AG (OTCMKTS:RHHBY – Get Rating) saw a large growth in short interest in September. As of September 15th, there was short interest totalling 2,820,200 shares, a growth of 34.4% from the August 31st total of 2,097,800 shares. Based on an average daily trading volume, of 2,367,600 shares, the short-interest ratio is currently 1.2 days.
羅氏控股公司(Roche Holding AG)(場外交易代碼：RHHBY-GET Rating)9月份空頭股數股價大幅增長。截至9月15日，空頭股數共有2,820,200股，較8月31日的2,097,800股增長34.4%。以日均成交量2,367,600股計算，目前短息比率為1.2天。
Roche Stock Down 1.2 %
羅氏股價下跌1.2%
Shares of RHHBY stock traded down $0.49 on Friday, reaching $40.62. The company's stock had a trading volume of 1,986,635 shares, compared to its average volume of 1,930,656. The company has a current ratio of 0.93, a quick ratio of 0.73 and a debt-to-equity ratio of 0.57. Roche has a 12-month low of $37.88 and a 12-month high of $53.86. The stock's 50 day simple moving average is $41.30 and its 200-day simple moving average is $43.42.
上週五，RHHBY股價下跌0.49美元，至40.62美元。該公司股票的成交量為1,986,635股，而其平均成交量為1,930,656股。該公司的流動比率為0.93，速動比率為0.73，債務權益比率為0.57。羅氏的12個月低點為37.88美元，12個月高位為53.86美元。該股的50日簡單移動均線切入位為41.30美元，200日簡單移動均線切入位為43.42美元。
Institutional Investors Weigh In On Roche
機構投資者參與羅氏
A number of large investors have recently added to or reduced their stakes in the company. Captrust Financial Advisors increased its holdings in shares of Roche by 15.0% in the second quarter. Captrust Financial Advisors now owns 46,398 shares of the company's stock worth $1,934,000 after buying an additional 6,041 shares during the period. Madison Asset Management LLC bought a new stake in shares of Roche in the second quarter worth about $2,097,000. Boston Common Asset Management LLC grew its stake in shares of Roche by 8.6% in the second quarter. Boston Common Asset Management LLC now owns 651,564 shares of the company's stock worth $27,100,000 after purchasing an additional 51,537 shares during the last quarter. Altrius Capital Management Inc bought a new stake in shares of Roche in the second quarter worth about $4,037,000. Finally, Tevis Investment Management grew its stake in shares of Roche by 46.8% in the second quarter. Tevis Investment Management now owns 17,626 shares of the company's stock worth $731,000 after purchasing an additional 5,621 shares during the last quarter. Hedge funds and other institutional investors own 0.23% of the company's stock.
一些大型投資者最近增持或減持了該公司的股份。CapTrust Financial Advisors在第二季度增持了15.0%的羅氏股票。CapTrust Financial Advisors目前持有46,398股該公司股票，價值1,934,000美元，在此期間又購買了6,041股。麥迪遜資產管理公司(Madison Asset Management LLC)在第二季度購買了價值約2,097,000美元的羅氏新股。波士頓共同資產管理有限責任公司在第二季度增持了8.6%的羅氏股票。波士頓共同資產管理公司(Boston Common Asset Management LLC)在上個季度額外購買了51,537股後，目前擁有651,564股該公司股票，價值27，10萬美元。Altrius Capital Management Inc.在第二季度購買了價值約4,037,000美元的羅氏新股。最後，Tevis投資管理公司在第二季度增持了46.8%的羅氏股票。Tevis投資管理公司在上個季度又購買了5621股，現在擁有17626股該公司股票，價值73.1萬美元。對衝基金和其他機構投資者持有該公司0.23%的股票。
Wall Street Analysts Forecast Growth
華爾街分析師預測經濟增長
Roche Company Profile
羅氏公司簡介
(Get Rating)
(獲取評級)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation.
羅氏控股公司在瑞士、德國、美國、奧地利、荷蘭、英國、法國、比利時和國際上從事製藥和診斷業務。該公司提供治療腫瘤學、神經科學、感染學、免疫學、心血管和新陳代謝、眼科和呼吸系統以及貧血、癌症、皮膚科、血友病、炎症和自身免疫、神經科和移植的藥物。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on Roche (RHHBY)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Let Paychex Stock Work Hard For You
- Declining Profits Challenge the CarMax Value Proposition
- 免費獲取StockNews.com關於羅氏的研究報告(RHHBY)
- 電動汽車電池製造商Freyr將在全球大舉擴張
- MarketBeat：回顧一週9/26-9/30
- 這是買入美光科技的難忘時刻
- 讓Paychex股票為您努力工作
- 利潤下降對CarMax價值主張的挑戰
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
接受《羅氏日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對羅氏和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧